Cargando…

Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer

BACKGROUND: Effective biomarkers for early diagnosis of lung cancer are needed. Previous studies have indicated positive associations between abnormal circulating cytokines and the etiology of lung cancer. METHODS: Blood samples were obtained from 286 patients with pretreatment lung cancer and 80 he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Peng-Fei, Ma, Yu-Chen, Yue, Dong-Sheng, Liang, Fan, Li, Chen-Guang, Chen, Chen, Zhang, Hua, Sun, Xiao-Yan, Huang, Wu-Hao, Zhang, Zhen-Fa, Zhou, Guang-Biao, Wang, Gui-Zhen, Zhang, Bin, Wang, Chang-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235466/ https://www.ncbi.nlm.nih.gov/pubmed/35769715 http://dx.doi.org/10.3389/fonc.2022.833866

Ejemplares similares

CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities
por: Gao, San-Hui, et al.
Publicado: (2021)

Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer
por: Li, Longhai, et al.
Publicado: (2019)

Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
por: Li, Mei-Yong, et al.
Publicado: (2021)

Plasma Extracellular Vesicle Long RNAs Have Potential as Biomarkers in Early Detection of Colorectal Cancer
por: Guo, Tian-An, et al.
Publicado: (2022)

Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
por: Yin, Chengliang, et al.
Publicado: (2020)

CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Serum Chemokine CXCL7 as a Potential Novel Biomarker for Obstructive Colorectal Cancer
por: Li, Longhai, et al.
Publicado: (2021)

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma
por: Li, Junfeng, et al.
Publicado: (2023)

Urinary malate dehydrogenase 2 is a new biomarker for early detection of non‐small‐cell lung cancer
por: Ma, Yu‐Chen, et al.
Publicado: (2021)

Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
por: Han, Jiayi, et al.
Publicado: (2020)

Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases
por: Zhang, Tianhao, et al.
Publicado: (2021)

Effects of BMPER, CXCL10, and HOXA9 on Neovascularization During Early-Growth Stage of Primary High-Grade Glioma and Their Corresponding MRI Biomarkers
por: Xue, Wei, et al.
Publicado: (2020)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023)

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
por: Liang, Yuan-ke, et al.
Publicado: (2021)

Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zhang, Shan-Qiang, et al.
Publicado: (2022)

The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution
por: Wang, Gui-Zhen, et al.
Publicado: (2015)

Prediction of outcomes by diffusion kurtosis imaging in patients with large (≥5 cm) hepatocellular carcinoma after liver resection: A retrospective study
por: Qin, Yun-Long, et al.
Publicado: (2022)

REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
por: Zhou, Shu-Guang, et al.
Publicado: (2022)

FOXS1 Promotes Tumor Progression by Upregulating CXCL8 in Colorectal Cancer
por: Qiu, Junfeng, et al.
Publicado: (2022)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

Plasma Dermatology: Skin Therapy Using Cold Atmospheric Plasma
por: Tan, Fei, et al.
Publicado: (2022)

Editorial: Biomarkers, functional mechanisms, and therapeutic potentials in gastrointestinal cancers
por: Huang, Jun, et al.
Publicado: (2023)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022)

Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Qu, Genyi, et al.
Publicado: (2022)

Determination of monosaccharide composition in human serum by an improved HPLC method and its application as candidate biomarkers for endometrial cancer
por: Chen, Yulong, et al.
Publicado: (2022)

Prediction of extracapsular extension in prostate cancer using the Likert scale combined with clinical and pathological parameters
por: Wang, Jun-guang, et al.
Publicado: (2023)

Association Between Unstable Angina and CXCL17: a New Potential Biomarker
por: Gong, Fu-han, et al.
Publicado: (2019)

Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer
por: Liu, Bo, et al.
Publicado: (2022)

The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors
por: Zhang, Xu, et al.
Publicado: (2023)

Identification of Candidate Biomarker ASXL2 and Its Predictive Value in Pancreatic Carcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets
por: Roberto, Michela, et al.
Publicado: (2023)

Dramatic response to neoadjuvant savolitinib in marginally resectable lung adenocarcinoma with MET exon 14 skipping mutation: A case report and literature review
por: Tian, Jiangfang, et al.
Publicado: (2022)

Plasma exosomal tRNA‐derived fragments as diagnostic biomarkers in non-small cell lung cancer
por: Zheng, Baibing, et al.
Publicado: (2022)

Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer
por: Yang, Jie, et al.
Publicado: (2021)

Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer
por: Chen, Mengqing, et al.
Publicado: (2021)

A Novel Model Based on CXCL8-Derived Radiomics for Prognosis Prediction in Colorectal Cancer
por: Chu, Yanpeng, et al.
Publicado: (2020)

A Three lncRNA Set: AC009975.1, POTEH-AS1 and AL390243.1 as Nodal Efficacy Biomarker of Neoadjuvant Therapy for HER-2 Positive Breast Cancer
por: Bi, Zhao, et al.
Publicado: (2021)

Development and verification of prognostic nomogram for ampullary carcinoma based on the SEER database
por: Tang, Nan, et al.
Publicado: (2023)

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
por: Cheng, Qianwen, et al.
Publicado: (2021)

Proteomics-Based Identification of Candidate Exosomal Glycoprotein Biomarkers and Their Value for Diagnosing Colorectal Cancer
por: Sun, Zujun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_23qfb0v75tua5ns4omo4dnqi73